Global Oral Solid Dosage Pharmaceutical Formulation Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 12-Jul-2021
No. of pages: 97
Inquire Before Buying

Oral solid dosage forms are the most commonly used pharmaceuticals to treat various disease conditions. Oral solid dosage forms are cost-effective and easy to manufacture in comparison with other dosage forms. They offer significant benefits to manufacturers such as trouble free packaging and transportation and increased chemical and physical stability. Oral solids offer many advantages to patients as well.

North America dominated the global oral solid dosage pharmaceutical formulation market in revenue terms in 2017, and the trend is projected to continue throughout the forecast period.

Market Analysis and Insights: Global Oral Solid Dosage Pharmaceutical Formulation Market

The global Oral Solid Dosage Pharmaceutical Formulation market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oral Solid Dosage Pharmaceutical Formulation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oral Solid Dosage Pharmaceutical Formulation market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oral Solid Dosage Pharmaceutical Formulation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oral Solid Dosage Pharmaceutical Formulation market.

Global Oral Solid Dosage Pharmaceutical Formulation Scope and Market Size

Oral Solid Dosage Pharmaceutical Formulation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Solid Dosage Pharmaceutical Formulation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Immediate Release

- Extended Release

- Others

Segment by Application

- Hospital Pharmacy

- Retail Pharmacy

- Drug Stores

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- AstraZeneca

- Bristol-Myers Squibb

- Eli Lilly

- Gilead

- Merck

- Novartis

- Pfizer

- AbbVie

- Boehringer Ingelheim

Global Oral Solid Dosage Pharmaceutical Formulation Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immediate Release
1.2.3 Extended Release
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Drug Stores
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Perspective (2016-2027)
2.2 Oral Solid Dosage Pharmaceutical Formulation Growth Trends by Regions
2.2.1 Oral Solid Dosage Pharmaceutical Formulation Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oral Solid Dosage Pharmaceutical Formulation Historic Market Share by Regions (2016-2021)
2.2.3 Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Regions (2022-2027)
2.3 Oral Solid Dosage Pharmaceutical Formulation Industry Dynamic
2.3.1 Oral Solid Dosage Pharmaceutical Formulation Market Trends
2.3.2 Oral Solid Dosage Pharmaceutical Formulation Market Drivers
2.3.3 Oral Solid Dosage Pharmaceutical Formulation Market Challenges
2.3.4 Oral Solid Dosage Pharmaceutical Formulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Solid Dosage Pharmaceutical Formulation Players by Revenue
3.1.1 Global Top Oral Solid Dosage Pharmaceutical Formulation Players by Revenue (2016-2021)
3.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Players (2016-2021)
3.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oral Solid Dosage Pharmaceutical Formulation Revenue
3.4 Global Oral Solid Dosage Pharmaceutical Formulation Market Concentration Ratio
3.4.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Solid Dosage Pharmaceutical Formulation Revenue in 2020
3.5 Oral Solid Dosage Pharmaceutical Formulation Key Players Head office and Area Served
3.6 Key Players Oral Solid Dosage Pharmaceutical Formulation Product Solution and Service
3.7 Date of Enter into Oral Solid Dosage Pharmaceutical Formulation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Type
4.1 Global Oral Solid Dosage Pharmaceutical Formulation Historic Market Size by Type (2016-2021)
4.2 Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Type (2022-2027)
5 Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Application
5.1 Global Oral Solid Dosage Pharmaceutical Formulation Historic Market Size by Application (2016-2021)
5.2 Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size (2016-2027)
6.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type
6.2.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021)
6.2.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027)
6.2.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2027)
6.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application
6.3.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021)
6.3.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027)
6.3.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2027)
6.4 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country
6.4.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2016-2021)
6.4.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size (2016-2027)
7.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type
7.2.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021)
7.2.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027)
7.2.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2027)
7.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application
7.3.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021)
7.3.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027)
7.3.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2027)
7.4 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country
7.4.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2016-2021)
7.4.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size (2016-2027)
8.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Type
8.2.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2027)
8.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Application
8.3.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2027)
8.4 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Region
8.4.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size (2016-2027)
9.2 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type
9.2.1 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021)
9.2.2 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027)
9.2.3 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2027)
9.3 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application
9.3.1 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021)
9.3.2 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027)
9.3.3 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2027)
9.4 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country
9.4.1 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2016-2021)
9.4.2 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size (2016-2027)
10.2 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type
10.2.1 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2027)
10.3 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application
10.3.1 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2027)
10.4 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country
10.4.1 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Introduction
11.1.4 AstraZeneca Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Introduction
11.2.4 Bristol-Myers Squibb Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Introduction
11.3.4 Eli Lilly Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Gilead
11.4.1 Gilead Company Details
11.4.2 Gilead Business Overview
11.4.3 Gilead Oral Solid Dosage Pharmaceutical Formulation Introduction
11.4.4 Gilead Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.4.5 Gilead Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Oral Solid Dosage Pharmaceutical Formulation Introduction
11.5.4 Merck Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Oral Solid Dosage Pharmaceutical Formulation Introduction
11.6.4 Novartis Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Oral Solid Dosage Pharmaceutical Formulation Introduction
11.7.4 Pfizer Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Oral Solid Dosage Pharmaceutical Formulation Introduction
11.8.4 AbbVie Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.8.5 AbbVie Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Introduction
11.9.4 Boehringer Ingelheim Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.9.5 Boehringer Ingelheim Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immediate Release
Table 3. Key Players of Extended Release
Table 4. Key Players of Others
Table 5. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Regions (2016-2021)
Table 9. Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Regions (2022-2027)
Table 11. Oral Solid Dosage Pharmaceutical Formulation Market Trends
Table 12. Oral Solid Dosage Pharmaceutical Formulation Market Drivers
Table 13. Oral Solid Dosage Pharmaceutical Formulation Market Challenges
Table 14. Oral Solid Dosage Pharmaceutical Formulation Market Restraints
Table 15. Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Players (2016-2021)
Table 17. Global Top Oral Solid Dosage Pharmaceutical Formulation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Solid Dosage Pharmaceutical Formulation as of 2020)
Table 18. Ranking of Global Top Oral Solid Dosage Pharmaceutical Formulation Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Oral Solid Dosage Pharmaceutical Formulation Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oral Solid Dosage Pharmaceutical Formulation Product Solution and Service
Table 22. Date of Enter into Oral Solid Dosage Pharmaceutical Formulation Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type (2016-2021)
Table 26. Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Application (2016-2021)
Table 30. Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2022-2027) & (US$ Million)
Table 62. AstraZeneca Company Details
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Product
Table 65. AstraZeneca Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 66. AstraZeneca Recent Development
Table 67. Bristol-Myers Squibb Company Details
Table 68. Bristol-Myers Squibb Business Overview
Table 69. Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Product
Table 70. Bristol-Myers Squibb Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 71. Bristol-Myers Squibb Recent Development
Table 72. Eli Lilly Company Details
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Product
Table 75. Eli Lilly Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 76. Eli Lilly Recent Development
Table 77. Gilead Company Details
Table 78. Gilead Business Overview
Table 79. Gilead Oral Solid Dosage Pharmaceutical Formulation Product
Table 80. Gilead Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 81. Gilead Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Oral Solid Dosage Pharmaceutical Formulation Product
Table 85. Merck Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Oral Solid Dosage Pharmaceutical Formulation Product
Table 90. Novartis Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Oral Solid Dosage Pharmaceutical Formulation Product
Table 95. Pfizer Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 96. Pfizer Recent Development
Table 97. AbbVie Company Details
Table 98. AbbVie Business Overview
Table 99. AbbVie Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 100. AbbVie Recent Development
Table 101. Boehringer Ingelheim Company Details
Table 102. Boehringer Ingelheim Business Overview
Table 103. Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Product
Table 104. Boehringer Ingelheim Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 105. Boehringer Ingelheim Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Type: 2020 VS 2027
Figure 2. Immediate Release Features
Figure 3. Extended Release Features
Figure 4. Others Features
Figure 5. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Drug Stores Case Studies
Figure 9. Others Case Studies
Figure 10. Oral Solid Dosage Pharmaceutical Formulation Report Years Considered
Figure 11. Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Regions: 2020 VS 2027
Figure 14. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Regions (2022-2027)
Figure 15. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Players in 2020
Figure 16. Global Top Oral Solid Dosage Pharmaceutical Formulation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Solid Dosage Pharmaceutical Formulation as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Oral Solid Dosage Pharmaceutical Formulation Revenue in 2020
Figure 18. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type (2016-2021)
Figure 19. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type (2022-2027)
Figure 20. North America Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2016-2027)
Figure 22. North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2016-2027)
Figure 23. North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2016-2027)
Figure 24. United States Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2016-2027)
Figure 28. Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2016-2027)
Figure 29. Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2016-2027)
Figure 30. Germany Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Share by Region (2016-2027)
Figure 40. China Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2016-2027)
Figure 48. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2016-2027)
Figure 49. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2016-2027)
Figure 50. Mexico Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2016-2027)
Figure 56. Turkey Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AstraZeneca Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 61. Eli Lilly Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 62. Gilead Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 66. AbbVie Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 67. Boehringer Ingelheim Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
  • Global Solubility Enhancement Excipients for OSDF Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 117
    Report Scope This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Solubility Enhancement Excipients for OSDF manufacturers, distributors, end users, indu......
  • Global Solid Tumors Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 125
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Solid Tumors Drugs manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry p......
  • Global Smoking Cessation Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 116
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Smoking Cessation Drugs manufacturers, distributors, end users, industry associations, governments' industry bureaus, indus......
  • Global Smoking Cessation Products Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 119
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Smoking Cessation Products manufacturers, distributors, end users, industry associations, governments' industry bureaus, in......
  • Global Agrobacterium tumefaciens Competent Cells Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 127
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Agrobacterium tumefaciens Competent Cells manufacturers, distributors, end users, industry associations, governments' indus......
  • Global Breast Cancer Therapeutics Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 134
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Breast Cancer Therapeutics Drugs manufacturers, distributors, end users, industry associations, governments' industry burea......
  • Global Irritable Bowel Syndrome with Constipation Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 109
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Irritable Bowel Syndrome with Constipation Drugs manufacturers, distributors, end users, industry associations, governments......
  • Global Urological Cancer Therapeutics Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 129
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Urological Cancer Therapeutics Drugs manufacturers, distributors, end users, industry associations, governments' industry b......
  • Global Amlexanox Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 88
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Amlexanox manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publicatio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs